Dyax Corp. (DYAX) in Focus: Stock Up 6% - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP)

Dyax Corp. DYAX was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 7.14% in the past one-month time frame.

In the last 30 days, the company witnessed 2 downward estimate revision, while the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

Dyax Corp. currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. ALXN, ANI Pharmaceuticals, Inc. ANIP and Aastrom Biosciences, Inc. ASTM all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALEXION PHARMA ALXN: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

AASTROM BIOSCI ASTM: Get Free Report

DYAX CORP DYAX: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs